Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.

Skelly DT., Harding AC., Gilbert-Jaramillo J., Knight ML., Longet S., Anthony Brown ., Adele S., Adland E., Brown H., Team ML., Tom Tipton ., Stafford L., Johnson SA., Amini A., Group OPTICC., Kit Tan T., Schimanski L., Huang K-YA., Rijal P., Group PITCHS., Group CP-C., Frater J., Goulder P., Conlon CP., Jeffery K., Dold C., Pollard AJ., Sigal A., de Oliveira T., Townsend AR., Klenerman P., Dunachie SJ., Barnes E., Carroll MW., James WS.

DOI

10.21203/rs.3.rs-226857/v2

Type

Preprint

Publication Date

2021-03-29T00:00:00+00:00

Permalink More information Close